Blueprint Medicines Corporation Analytics - Traffic, Statistics and Competitor Tracking


Blueprint Medicines Corporation Website Screenshot

http://www.blueprintmedicines.com

Blueprint Medicines Corporation Company Intro

Protein kinases (enzymes that modify the functions of proteins) are critical to controlling biochemical pathways and are involved in many hallmarks of tumor biology – yet currently approved drugs focus on less than 5% of known kinases.

Industry

Healthcare

Blueprint Medicines Corporation Headquaters

45 Sidney Street
Cambridge,02139
United States


Blueprint Medicines Corporation Share price

26 Jan 2021 01:15 GMT

$101.58

0.22 (0.22 %)


Blueprint Medicines Corporation Market cap

$5.735 B


WMC RANKING

2021

Blueprint Medicines Corporation # 85

Biotechnology

Latest Blueprint Medicines Corporation News

News 25 Jan 2021

World Conference on Lung Cancer set to fuel targeted drug ...

s Retevmo (selpercatinib) and Roche Holding AG and Blueprint Medicines Corp.'s Gavreto (pralsetinib) having gained FDA approval in 2020, WCLC doesn't ...

News 26 Jan 2021

Systemic Mastocytosis Treatment Market Key-Players & Forecast Research Report 2027 | AB Science SA, Patara Pharma Inc, Blueprint Medicines Corp, AbbVie Inc

Key Players: AB Science SA, Patara Pharma Inc, Blueprint Medicines Corp, AbbVie Inc, Novartis AG, Arog Pharmaceuticals Inc, Stemline Therapeutics Inc, ...

News 26 Jan 2021

Systemic Mastocytosis Treatment Market to witness ...

... astonishing growth with Key Players : AB Science SA, AbbVie Inc, Arog Pharmaceuticals Inc, Blueprint Medicines Corp, Bristol-Myers Squibb Company.


WMC Market Score


WMC Market to Revenue Score


Blueprint Medicines Corporation Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Blueprint Medicines Corporation USD $66,512 $427,838 $-347,694 $57,350B 85
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $584,960B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $352,840B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $627,500B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $271,200B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Blueprint Medicines Corporation Social Followers vs Top 4 Industry Competitors



Blueprint Medicines Corporation Post vs Top 4 Industry Competitors




Blueprint Medicines Corporation Digital Footprint By Size vs Top 4 Industry Competitors



Blueprint Medicines Corporation Digital Footprint By Change Rate vs Top 4 Industry Competitors



Blueprint Medicines Corporation WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Blueprint Medicines Corporation 0.72 2.91 16.08 0 0 0 9.84
Regeneron Pharmaceuticals, Inc. 100 66.54 29.44 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.37 100 60 0 0 90.05
Vertex Pharmaceuticals Incorporated 64.81 100 8.77 86 0 0 99.30
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries